Foslevodopa

Records for this ingredient, by country (identity only).

ATC N04BA07 · 6 markets · 8 records

Foslevodopa 6 markets · 8 records Forms
Filters
MarketAU 3US 1GB 1CA 1ES 1FR 1
Kind

AU 3 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Combination products containing this ingredient

  • 2,400 mg/10 mLinjection CombinationFoscarbidopa 120 mg/10 mL + Foslevodopa 2,400 mg/10 mLVyalev also in GB
  • 2,400 mg per mL / per unit basis not statedinjection CombinationFoscarbidopa 120 mg + Foslevodopa 2,400 mgVYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Vyalev ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

Combination products containing this ingredient

  • 240 mg per mL / per unit basis not statedinjection CombinationFoscarbidopa 12 mg + Foslevodopa 240 mgVyalev

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

Combination products containing this ingredient

  • 2,400 mg/10 mLinjection CombinationFoscarbidopa 120 mg/10 mL + Foslevodopa 2,400 mg/10 mLProduodopa 2.4g/10ml / 120mg/10ml solution for infusion vials also in AU

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Combination products containing this ingredient

  • 240 mg per mL / per unit basis not statedliquid CombinationFoscarbidopa 12 mg + Foslevodopa 240 mgVyalev

ES 1 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

Combination products containing this ingredient

  • 240 mg/1 mLinjection CombinationFoscarbidopa 12 mg/1 mL + Foslevodopa 240 mg/1 mLDUODOPA also in FR

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

Combination products containing this ingredient

  • 240 mg/1 mLinjection CombinationFoscarbidopa 12 mg/1 mL + Foslevodopa 240 mg/1 mLSCYOVA 240 mg/mL + 12 mg/mL, solution pour perfusion also in ES

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.